Peleg-Raibstein D, Sydekum E, Russig H, Feldon J
Laboratory of Behavioural Neurobiology, Swiss Federal Institute of Technology (ETH Zurich), Schwerzenbach, Switzerland.
J Neural Transm (Vienna). 2006 Sep;113(9):1323-36. doi: 10.1007/s00702-005-0390-5. Epub 2005 Dec 16.
The present study represents a continuous effort to develop an animal model of schizophrenia based on the "endogenous dopamine sensitization" hypothesis. To achieve this goal, withdrawal from an escalating amphetamine (AMPH) regime administration [three injections per day over a period of 4 days and increasing doses from 1 to 10 mg/kg of AMPH or an equivalent volume of saline (SAL)] was employed. Animals exposed to this treatment were evaluated on their performance in attentional (Latent inhibition, LI) and sensorimotor gating (Prepulse inhibition, PPI) tasks in a drug free state and tested for locomotor sensitization following a low dose of AMPH challenge administration.LI using active avoidance, tested on withdrawal day 4, was unaffected. PPI of the acoustic startle response, measured on withdrawal days 6 and 70, was disrupted. On the 76th day of withdrawal, a low challenge dose of AMPH (1 mg/kg) led to a clear locomotor sensitization effect.
本研究是基于“内源性多巴胺致敏”假说持续努力开发精神分裂症动物模型的成果。为实现这一目标,采用了逐步递增剂量的苯丙胺(AMPH)给药方案后停药的方法[在4天内每天注射3次,AMPH剂量从1毫克/千克增加到10毫克/千克,或注射等量体积的生理盐水(SAL)]。对接受该治疗的动物在无药物状态下的注意力(潜伏抑制,LI)和感觉运动门控(前脉冲抑制,PPI)任务表现进行评估,并在低剂量AMPH激发给药后测试其运动致敏情况。在停药第4天使用主动回避测试的LI未受影响。在停药第6天和第70天测量的听觉惊吓反应的PPI受到破坏。在停药第76天,低剂量的AMPH激发(1毫克/千克)导致明显的运动致敏效应。